RecallDepth
Class II Terminated

Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count (NDC 68180-590-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
October 23, 2024
Posted
November 27, 2024
Recall Number
D-0053-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
146,322 bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor

Distribution

Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.

Lot / Code Info

a) NDC 68180-590-09; Lots G326928, exp. date 30-Sep-25, GA00964, exp. date 31-Dec-25, b) NDC 68180-590-01, Lots G326897, G326929, exp. date 30-Sep-25, GA00854, GA00933, GA00954, exp. date 31-Dec-25, c) NDC 68180-590-02, Lot GA00955, exp. date 31-Dec-25

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls